Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

25.09.2017

1 Aktuelle Urol
1 Biomed Res Int
1 Cancer Res
1 Clin Cancer Res
1 Diabetologia
1 Eur J Epidemiol
2 Int J Clin Oncol
1 J Gastroenterol Hepatol
1 J Telemed Telecare
1 N Engl J Med
1 Nat Rev Urol
1 Neurourol Urodyn
3 Oncol Lett
2 Oncotarget
1 PLoS One
1 Sci Rep
1 Urol Oncol
2 Urology



    Aktuelle Urol

  1. CHRISTOPH F, Konig F, Lebentrau S, Blaschke S, et al
    [Thermochemotherapy with Mitomycin C: an update on alternative treatment strategies in non-muscleinvasive bladder cancer].
    Aktuelle Urol. 2017 Sep 19. doi: 10.1055/s-0043-109414.
    >> Share


    Biomed Res Int

  2. SZYMANSKA B, Sawicka E, Guzik A, Zdrojowy R, et al
    The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens.
    Biomed Res Int. 2017;2017:9643139.
    >> Share


    Cancer Res

  3. GOLDSTEIN JT, Berger AC, Shih J, Duke FF, et al
    Genomic activation of PPARG reveals a candidate therapeutic axis in bladder cancer.
    Cancer Res. 2017 Sep 18. pii: canres.1701.2017.
    >> Share


    Clin Cancer Res

  4. MARTINEZ VG, Rubio C, Martinez-Fernandez M, Segovia C, et al
    BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer.
    Clin Cancer Res. 2017 Sep 19. pii: clincanres.1004.2017.
    >> Share


    Diabetologia

  5. KOHLER S, Lee J, George JT, Inzucchi SE, et al
    Bladder cancer in the EMPA-REG OUTCOME trial.
    Diabetologia. 2017 Sep 14. doi: 10.1007/s00125-017-4430.
    >> Share


    Eur J Epidemiol

  6. WESSELIUS A, Zeegers M
    Re: Lifestyle and bladder cancer prevention: no consistent evidence from cohort studies.
    Eur J Epidemiol. 2017 Sep 19. doi: 10.1007/s10654-017-0307.
    >> Share


    Int J Clin Oncol

  7. TSUDA Y, Nakagawa T, Shinoda Y, Kanatani A, et al
    Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.
    Int J Clin Oncol. 2017;22:548-553.
    >> Share

  8. MATSUSHIMA M, Kikuchi E, Akita H, Miyajima A, et al
    Natural course of asymptomatic abnormal prostate findings incidentally detected by CT after intravesical BCG therapy.
    Int J Clin Oncol. 2017;22:554-562.
    >> Share


    J Gastroenterol Hepatol

  9. HAFERTEPE M, Nguyen BD
    Gastrointestinal: Recurrent urothelial cancer of the remnant ureter invading the ileal conduit: PET/CT imaging.
    J Gastroenterol Hepatol. 2017;32:291.
    >> Share


    J Telemed Telecare

  10. DEKALO S, Matzkin H, Mabjeesh NJ
    Can urologists accurately stage and grade urothelial bladder cancer by assessing endoscopic photographs?
    J Telemed Telecare. 2017 Jan 1:1357633X17727773. doi: 10.1177/1357633X17727773.
    >> Share


    N Engl J Med

  11. NGUYEN S, Choi C
    Neobladder Stone.
    N Engl J Med. 2017;377:977.
    >> Share


    Nat Rev Urol

  12. STONE L
    Bladder cancer: Shields up, red alert: the blebbishield emergency programme.
    Nat Rev Urol. 2017 Sep 19. doi: 10.1038/nrurol.2017.
    >> Share


    Neurourol Urodyn

  13. ALIMI Q, Hascoet J, Manunta A, Kammerer-Jacquet SF, et al
    Reliability of urinary cytology and cystoscopy for the screening and diagnosis of bladder cancer in patients with neurogenic bladder: A systematic review.
    Neurourol Urodyn. 2017 Sep 19. doi: 10.1002/nau.23395.
    >> Share


    Oncol Lett

  14. HORIKAWA Y, Watanabe M, Sadahira T, Ariyoshi Y, et al
    Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells.
    Oncol Lett. 2017;14:3223-3228.
    >> Share

  15. KANG HW, Kim YH, Jeong P, Park C, et al
    Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status.
    Oncol Lett. 2017;14:3817-3824.
    >> Share

  16. JIANG B, Dong Y, He H, Han C, et al
    Application of pirarubicin photosensitizer fluorescence cystoscopy in early detection of bladder cancer.
    Oncol Lett. 2017;14:3309-3312.
    >> Share


    Oncotarget

  17. JOHN BA, Said N
    Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.
    Oncotarget. 2017;8:57766-57781.
    >> Share

  18. HAN B, Shen Y, Zhang P, Jayabal P, et al
    Overlooked FANCD2 variant encodes a promising, portent tumor suppressor, and alternative polyadenylation contributes to its expression.
    Oncotarget. 2017;8:22490-22500.
    >> Share


    PLoS One

  19. DOWELL AC, Cobby E, Wen K, Devall AJ, et al
    Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.
    PLoS One. 2017;12:e0184841.
    >> Share


    Sci Rep

  20. THOMSEN MBH, Nordentoft I, Lamy P, Vang S, et al
    Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer.
    Sci Rep. 2017;7:11702.
    >> Share


    Urol Oncol

  21. LIMA L, Neves M, Oliveira MI, Dieguez L, et al
    Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.
    Urol Oncol. 2017 Sep 11. pii: S1078-1439(17)30422.
    >> Share


    Urology

  22. SCHROECK FR, Patterson OV, Alba PR, Pattison EA, et al
    Development of a Natural Language Processing Engine to Generate Bladder Cancer Pathology Data for Health Services Research.
    Urology. 2017 Sep 12. pii: S0090-4295(17)30966.
    >> Share

  23. PARKER WP, Toussi A, Tollefson MK, Frank I, et al
    Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical Cystectomy.
    Urology. 2016 Apr 25. pii: S0090-4295(16)30114.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016